3568|267|Public
5|$|Low-density {{lipoprotein}} receptor-related protein 8 (LRP8), {{also known}} as <b>apolipoprotein</b> <b>E</b> receptor 2 (ApoER2), is a protein that in humans is encoded by the LRP8 gene.|$|E
5|$|There is also modest {{evidence}} that genetic factors influence the prognosis in SAH. For example, having {{two copies of}} ApoE4 (a variant of the gene encoding <b>apolipoprotein</b> <b>E</b> that also {{plays a role in}} Alzheimer's disease) seems to increase risk for delayed ischemia and a worse outcome. The occurrence of hyperglycemia (high blood sugars) after an episode of SAH confers a higher risk of poor outcome.|$|E
5|$|<b>Apolipoprotein</b> <b>E</b> (ApoE) {{plays an}} {{important}} role in phospholipid and cholesterol homeostasis. After binding ApoER2, ApoE is taken up into the cell and may remain in the intracellular space, be shipped to the cell surface, or be degraded. ApoE binding leads to the cleavage of ApoER2 into secreted proteins by the actions of the plasma membrane protein gamma secretase. ApoE may be the signalling ligand responsible for ApoER2's role in modulating the JNK signalling pathway.|$|E
40|$|The {{presence}} of <b>apolipoproteins</b> A-I, <b>E,</b> C-II, and C-III {{and the absence}} of apolipoprotein B was demonstrated in human cerebrospinal fluid. The concentration of apolipoproteins was measured by electroimmunoassay. <b>Apolipoproteins</b> <b>E,</b> C-II, and C-III were present in cerebrospinal fluid at 3 [...] 5 % of their concentration in plasma; the cerebrospinal fluid level of apolipoprotein A-I was 0. 4 %. Most of the cerebrospinal fluid apolipoproteins were present in the rho less than 1. 21 g/ml lipoprotein fraction. The major apolipoporteins of cerebrospinal fluid are E and A-I. The possible mechanism of transfer and the physiological and pathophysiological role of apolipoproteins in cerebrospinal fluid are postulated...|$|R
40|$|Defective {{clearance}} of the amyloid-β peptide (Aβ) {{from the}} brain is considered a strong promoter in Alzheimer's disease (AD) pathogenesis. Astrocytes and microglia are important mediators of Aβ clearance and Aβ aggregation state {{and the presence of}} amyloid associated proteins (AAPs), such as <b>Apolipoproteins</b> <b>E</b> and J (ApoE and ApoJ), may influence Aβ clearance by these cells. Here we set out to investigate whether astrocytes and microglia differ in uptake efficiency of Aβ oligomers (A...|$|R
40|$|Aims. We {{sought to}} {{identify}} biochemical predictors that indicate susceptibility to in-stent restenosis (ISR) after coronary artery bare-metal stenting. Methods. A total of 111 consecutive patients with post–percutaneous coronary intervention (PCI) in-stent restenosis {{of a target}} lesion within 12 months were matched for age, sex, vessel diameter, and diabetes with 111 controls without post–PCI ISR. Plasma or serum levels of biochemical markers were measured: matrix metalloproteinases (MMP) 2, 3, 9; myeloperoxidase (MPO); asymmetric dimethylarginine (ADMA); lipoprotein (a) (Lp[a]); <b>apolipoproteins</b> <b>E</b> and D (ApoE and D); and lecitin-cholesterol acyltransferase (LCAT). Multivariable logistic regression association tests were performed...|$|R
5|$|Most {{cases of}} Alzheimer's disease do not exhibit autosomal-dominant {{inheritance}} and are termed sporadic AD, in which environmental and genetic differences may act as risk factors. The best known genetic risk {{factor is the}} inheritance of the ε4 allele of the <b>apolipoprotein</b> <b>E</b> (APOE). Between 40 and 80% of people with AD possess at least one APOEε4 allele. The APOEε4 allele {{increases the risk of}} the disease by three times in heterozygotes and by 15 times in homozygotes. Like many human diseases, environmental effects and genetic modifiers result in incomplete penetrance. For example, certain Nigerian populations do not show the relationship between dose of APOEε4 and incidence or age-of-onset for Alzheimer's disease seen in other human populations. Early attempts to screen up to 400 candidate genes for association with late-onset sporadic AD (LOAD) resulted in a low yield. More recent genome-wide association studies (GWAS) have found 19 areas in genes that appear to affect the risk. These genes include: CASS4, CELF1, FERMT2, HLA-DRB5, INPP5D, MEF2C, NME8, PTK2B, SORL1, ZCWPW1, SlC24A4, CLU, PICALM, CR1, BIN1, MS4A, ABCA7, EPHA1, and CD2AP.|$|E
25|$|High {{levels of}} CRP has been {{associated}} to point mutation Cys130Arg in APOE gene, coding for <b>apolipoprotein</b> <b>E,</b> establishing a link between lipid values and inflammatory markers modulation.|$|E
25|$|In {{the blood}} stream, nascent VLDL {{particles}} bump with HDL particles; as a result, HDL particles donate apolipoprotein C-II and <b>apolipoprotein</b> <b>E</b> to the nascent VLDL particle. Once loaded with apolipoproteins C-II and E, the nascent VLDL particle is considered mature.|$|E
30|$|Receptor-mediated {{endocytosis}} may {{be responsible}} for nanoparticle entry through the blood brain barrier [37]. This method relies on the conjugation of ligands or peptides to receptors that bind nanoparticles {{to the surface of the}} endothelial cells [11]. Surfactants such as poloxamer 188 or polysorbate 80 may be used to coat nanoparticles to increase adsorption of serum proteins such as <b>apolipoproteins</b> <b>E</b> or A–I and thus enhance penetration through the BBB [38]. Covalent attachment of apolipoproteins to human serum albumin-coated nanoparticles may also improve their ability to cross the BBB [39]. Use of targeting ligands that bind to receptors on endothelial cells, such as transferrin, lactoferrin, and low-density lipoprotein receptors, may also promote BBB penetration [37, 40, 41].|$|R
40|$|We {{present the}} {{genotyping}} of <b>apolipoprotein</b> (apo) <b>E</b> {{by means of}} restriction fragment analysis of amplified genomic DNA by high-performance capillary electro-phoresis and a replaceable non-gel-sieving matrix. This procedure streamlines the genotyping of apo E in large-scale population studies because of the automation and speed of capillary electrophoresis. INDEXING TERMS: genotype determination • Alzheimer disease • high-performance capillary electrophoresis <b>Apolipoprotein</b> (apo) <b>E</b> is an important constituent of several plasma lipoproteins, mainly VLDL and HDL and chylomycrons. 3 It {{is involved in the}} redistribution of lipids in the liver and is implicated in growth and repair of injured neurons in the nervous system [1]. Apo E has been associated with the risk of developing cardiovascu...|$|R
40|$|Background: The {{association}} of the <b>apolipoprotein</b> (Apo <b>E)</b> -epsilon 4 allele to neurodegenerative diseases such as Parkinson’s disease (PD) has been analyzed in several studies. This association has been identified by amyloid deposits and neurofibrillary tangles in the brains of patients with neurodegenerative diseases...|$|R
25|$|VLDL {{molecules}} {{are produced}} by the liver from triacylglycerol and cholesterol which was not used in the synthesis of bile acids. These molecules contain apolipoprotein B100 and <b>apolipoprotein</b> <b>E</b> in their shells, and are degraded by lipoprotein lipase on the blood vessel wall to IDL.|$|E
25|$|There {{is also an}} {{overexpression}} of IgG-free kappa {{light chain}} protein in both CIS and RR-MS patients, compared with control subjects, together with an increased expression of an isoforms of <b>apolipoprotein</b> <b>E</b> in RR-MS. Expression of some specific proteins in circulating CD4+ T cells is {{a risk factor for}} conversion from CIS to clinically defined multiple sclerosis.|$|E
25|$|The hydrolyzed {{chylomicron}}s are {{now called}} chylomicron remnants. The chylomicron remnants continue circulating the bloodstream until they interact via <b>apolipoprotein</b> <b>E</b> with chylomicron remnant receptors, found chiefly in the liver. This interaction causes the endocytosis of the chylomicron remnants, which are subsequently hydrolyzed within lysosomes. Lysosomal hydrolysis releases glycerol and fatty acids into the cell, {{which can be}} used for energy or stored for later use.|$|E
40|$|The binding of a galactosylceramide analog to {{proteins}} in normal human cerebrospinal fluid was examined by photoaffinity labeling using a radioiodulabeled 2 -(p-azidosalicylamido) ethyl- 1, 3 -dithiopropionate derivative of galactosylsphingosine as a probe. The affinity-bound peptides appeared at 66, 36 and 28 kDa as radiolabeled bands. The latter two peptides, 36 and 28 kDa, were independently identified by immunostaining of the isolated peptides using biotinylated galactosylsphingosine, the chemical structure {{of which was}} confirmed by nuclear magnetic resonance and mass- spectrometry, and immobilized Avidin, and by immunoprecipitation of the photolabeled peptide, to <b>apolipoproteins</b> <b>E</b> and A-I, respectively. The direct binding of the galactosylceramide analog to these apopeptides suggested that the existence in the body fluids or the transfer between the fluids and cells of the glycolipid was related to high density lipoprotein constructions...|$|R
40|$|Background. The " 1 Western " diet, sex, and <b>apolipoprotein</b> (Apo) <b>E</b> {{polymorphism}} {{have been}} implicated as codeterminants of lipid levels. Methods and Results. In a retrospective analysis, we evaluated the combined impact of dietary fat, sex, and Apo E phenotype on lipoprotein levels in 67 subjects fed two contrasting, metabolically controlled diets: one a "Western " diet, {{with a low}} polyunsaturated to saturated (P: S) fatty acid ratio and the othe...|$|R
40|$|Here {{we report}} an improved, simple method to assign the human <b>apolipoprotein</b> (apo) <b>E</b> {{genotype}} and its isoforms, apo E 2, apo E 3, and apo E 4. Genomic DNA was amplified with specific primers {{that included the}} polymorphic region of amino acids 112 and 158. Digestion of the product with Hhal resulted in unique fragments that were separated on Meta-Phor agarose instead of polyacrylamide. The pattern of unique DNA fragments obtained unequivocally characterizes the different apo E allele...|$|R
25|$|Chylomicrons, {{the least}} dense {{cholesterol}} transport molecules, contain apolipoprotein B-48, apolipoprotein C, and <b>apolipoprotein</b> <b>E</b> (the principal cholesterol carrier in the brain) in their shells. Chylomicrons carry fats from the intestine to muscle and other tissues {{in need of}} fatty acids for energy or fat production. Unused cholesterol remains in more cholesterol-rich chylomicron remnants, and taken up from here to the bloodstream by the liver.|$|E
25|$|The {{major cause}} of DLB is not well {{understood}} yet, but a genetic link with the PARK11 gene has been described. As with Alzheimer's disease and Parkinson's disease, most cases of DLB appear sporadically and DLB is not thought {{to have a strong}} hereditary link. As with Alzheimer's disease, the DLB risk is heightened with inheritance of the ε4 allele of the <b>apolipoprotein</b> <b>E</b> (APOE).|$|E
25|$|In {{the blood}} stream, nascent {{chylomicron}} particles interact with HDL particles resulting in HDL donation of apolipoprotein C-II and <b>apolipoprotein</b> <b>E</b> to the nascent chylomicron. The chylomicron {{at this stage}} is then considered mature. Via apolipoprotein C-II, mature chylomicrons activate lipoprotein lipase (LPL), an enzyme on endothelial cells lining the blood vessels. LPL catalyzes the hydrolysis of triacylglycerol (glycerol covalently joined to three fatty acids) that ultimately releases glycerol and fatty acids from the chylomicrons. Glycerol and fatty acids can then be absorbed in peripheral tissues, especially adipose and muscle, for energy and storage.|$|E
40|$|Sequence {{comparisons}} of vitellogenins {{from a wide}} range of organisms have identified regions of similarity not only to each other but also to vertebrate <b>apolipoproteins</b> (<b>e.</b> g. apoB- 100 and apoE). Furthermore, the chicken vitellogenin receptor, which also binds apolipoproteins receptor (LDLR) superfamily [Bujo, H., Hermann, M., Kaderli, M. O., Jacobsen, L., Sugawara, S., Nimpf, J., Yamamoto, T. & Schneider, W. J. (1994) EMBO J. 13, 5165 - 5175]. The yolk proteins of higher dipterans are exceptional, however, and instead show similarity to lipoprotein lipases. The molecular characterization of the putative Drosophila melanogaster vitellogenin receptor gene, yolkless (yl), described in this report reveals that the protein it encodes (Yl), is also a member of the LDLR superfamily. The ovary-specific 6. 5 -kb yl RNA codes for a protein of approximately 210 kDa which contains all three motifs common to the LDLR class of proteins. Within this superfamily, Yl may be related more to the LDLR-related proteins (LRPs), which bind both apolipoproteins and lipoprotein lipases. The similarity of Yl to the other LDLR proteins is restricted to the putative extracellular domain. Most noticeably, the cytoplasmic domain of Yl lacks the typical NPXY sequence which is involved in receptor internalization...|$|R
40|$|<b>Apolipoprotein</b> (apo) <b>E,</b> an arginine-rich {{glycoprotein}} with {{a molecular}} mass of 34 kDa, is localized on chy-lomicrons, VLDL, intermediate-den-sity lipoprotein, and HDL particles. Apo E {{is important for}} the regulation of triglyceride-rich lipoproteins in humans and binds to the VLDL re-ceptor, LDL receptor, and LDL-re-ceptor-related protein. This process allows apo E to compensate partially for the function of defective apo B- 100 in humans (1). There are three different apo E alleles, 2 (frequency, 10 %), 3 (frequency, 75 %), and...|$|R
40|$|Megalin/gp 330 is an endocytic {{receptor}} that internalizes multiple ligands including <b>apolipoproteins</b> <b>E</b> (apo E) and B 100 (apo B). Megalin is {{the main}} antigenic target in passive Heymann nephritis (pHN), where it binds circulating autoantibodies leading {{to the formation of}} subepithelial immune deposits (ID) -the hallmark of pHN. Apo E and apo B were found recently to accumulate within these IDs, and evidence was provided that their lipids may undergo peroxidation, causing glomerular basement membrane damage and proteinuria. Here we investigated if ID-forming antimegalin IgG can inhibit the binding and internalization of apo E-betaVLDL (very low density lipoprotein) by megalin, and lead to their accumulation within IDs. By immunoelectron microscopy, apo E and apo B were detected in clathrin-coated pits and multivesicular bodies of podocytes in control rats, suggesting that the uptake of lipoproteins is a constitutive function of the glomerular epithelium. When pHN was induced by intravenous injection of antimegalin IgG, apo E and apo B were found within IDs by immunofluorescence and immunoelectron microscopy. Bound antibodies eluted from glomeruli of rats with pHN were found to inhibit the binding and internalization of apo E-enriched betaVLDL by megalin. These results indicate that pHN-inducing antimegalin IgG is capable of interfering with the uptake of lipoproteins by megalin in vivo during the formation of IDs...|$|R
25|$|Again, like chylomicrons, VLDL {{particles}} circulate and encounter {{lipoprotein lipase}} (LPL) expressed on endothelial cells. Apolipoprotein C-II activates LPL, causing hydrolysis of the VLDL particle {{and the release}} of glycerol and fatty acids. These products can be absorbed from the blood by peripheral tissues, principally adipose and muscle. The hydrolyzed VLDL particles are now called VLDL remnants or intermediate-density lipoproteins (IDLs). VLDL remnants can circulate and, via an interaction between <b>apolipoprotein</b> <b>E</b> and the remnant receptor, be absorbed by the liver, or they can be further hydrolyzed by hepatic lipase.|$|E
25|$|Individual {{factors of}} {{potential}} importance are genetic factors, prior radiation exposure, and previous head injury, such as concussion. <b>Apolipoprotein</b> <b>E</b> (ApoE) {{has been shown}} to be an important and common factor in CNS responses. ApoE controls the redistribution of lipids among cells and is expressed at high levels in the brain. New studies are considering the effects of space radiation for the major isoforms of ApoE, which are encoded by distinct alleles (ε2, ε3, and ε4). The isoform ApoE ε4 {{has been shown to}} increase the risk of cognitive impairments and to lower the age for Alzheimer’s disease. It is not known whether the interaction of radiation sensitivity or other individual risks factors is the same for high- and low-LET radiation. Other isoforms of ApoE confer a higher risk for other diseases. People who carry at least one copy of the ApoE ε4 allele are at increased risk for atherosclerosis, which is also suspected to be a risk increased by radiation. People who carry two copies of the ApoE ε2 allele are at risk for a condition that is known as hyperlipoproteinemia type III. It will therefore be extremely challenging to consider genetic factors in a multipleradiation-risk paradigm.|$|E
25|$|Studies {{have looked}} into the risk factors that {{are more prone to}} Japanese Americans, {{specifically}} in hundreds of family generations of Nisei (The generation of people born in North America, Latin America, Hawaii, or any country outside Japan either to at least one Issei or one non-immigrant Japanese parent) second-generation pro-bands (A person serving as the starting point for the genetic study of a family, used in medicine and psychiatry). The risk factors for genetic diseases in Japanese Americans include coronary heart disease and diabetes. One study, called the Japanese American Community Diabetes Study that started in 1994 and went through 2003, involved the pro-bands taking part to test whether the increased risk of diabetes among Japanese Americans is due to the effects of Japanese Americans having a more westernized lifestyle due to the many differences between the United States of America and Japan. One of the main goals {{of the study was to}} create an archive of DNA samples which could be used to identify which diseases are more susceptible in Japanese Americans. Concerns with these studies of the risks of inherited diseases in Japanese Americans is that information pertaining to the genetic relationship may not be consistent with the reported biological family information given of Nisei second generation pro-bands. Also, research has been put on concerning <b>apolipoprotein</b> <b>E</b> genotypes; this polymorphism has three alleles (*e2, *e3, and *e4)and was determined from research because of its known association with increased cholesterol levels and risk of coronary heart disease in Japanese Americans. Specifically too, the apolipoprotein *e4 allele is linked to Alzheimer’s disease as well. Also, there is increased coronary heart disease in Japanese-American men with a mutation in the cholesterol ester transfer protein gene despite having increased levels of HDL. By definition, HDL are plasma high density lipoproteins that show a genetic relationship with coronary heart disease (CHD). The cholesterol ester transfer protein(CETP) helps the transfer of cholesterol esters from lipoproteins to other lipoproteins in the human body. It plays a fundamental role in the reverse transport of cholesterol to the liver, which is why a mutation in this can lead to coronary heart disease. Studies have shown that the CETP is linked to increased HDL levels. There is a very common pattern of two different cholesterol ester transfer protein gene mutations (D442G, 5.1%; intron 14G:A, 0.5%) found in about 3,469 Japanese American men. This was based off a program called the Honolulu Heart Program. The mutations correlated with decreased CETP levels (-35%) and increased HDL cholesterol levels (+10% for D442G). The relative risk of CHD was 1.43 in men with mutations (P<0.05), and after research found for CHD risk factors, the relative risk went up to 1.55 (P=0.02); after further adjustments for HDL levels, the relative risk went up again to 1.68 (P=0.008). Genetic CETP deficiency is an independent risk factor for coronary heart disease, which is due mainly to increased CHD risks in Japanese American men with the D442G mutation and lipoprotein cholesterol levels between 41 and 60nbsp&mg/dl. With research and investigations, the possibility of finding “bad genes” denounces the Japanese Americans and will be associated only with Japanese American ancestry, leading to other issues the Japanese Americans had to deal with in the past such as discrimination and prejudice.|$|E
40|$|Macrophage-specific {{expression}} of <b>apolipoprotein</b> (apo) <b>E</b> protects against atherosclerosis; however, the signaling and trafficking pathways regulating secretion of apoE are unknown. We investigated {{the roles of}} the actin skeleton, microtubules, protein kinase A (PKA) and calcium (Ca 2 +) in regulating apoE secretion from macrophages. Disrupting microtubules with vinblastine or colchicine inhibited basal secretion of apoE substantially, whereas disruption of the actin skeleton had no effect. Structurally distinct inhibitors of PKA (H 89, KT 5720, inhibitory peptide PKI 14 - 22) all decreased basal secretion of apoE by between 50...|$|R
2500|$|A {{significant}} amount of {{research in this area}} has been spent exploring methods of nanoparticle-mediated delivery of antineoplastic drugs to tumors in the central nervous system. For example, radiolabeled polyethylene glycol coated hexadecylcyanoacrylate nanospheres targeted and accumulated in a rat gliosarcoma. However, this method is not yet ready for clinical trials, due to the accumulation of the nanospheres in surrounding healthy tissue. Another, more promising approach, is the coating of polyalkylcyanoacrylate or poly-lactic-co-glycolic acid (PLGA) nanoparticles with polysorbate 80 or poloxamer 188. [...] Due to this coating the particles [...] adsorb <b>apolipoproteins</b> <b>E</b> or A-1 from the blood and [...] thus interact with the LRP1 or with the scavenger receptor followed by transcytosis across the blood-brain barrier into the brain. These particles loaded with doxorubicin for the treatment of glioblastomas are presently in Clinical Phase I. Recently, a novel class of multifunctional nanoparticles known as magneto-electric nanoparticles (MENs) has been discovered for externally controlled targeted delivery and release of drug(s) across BBB as well as wireless stimulation of cells deep in the brain. This approach depends more on the field control and less on the cellular microenvironment. In vitro and in vivo (on mice) experiments to prove the feasibility of using MENs to release a drug across BBB on demand and wirelessly stimulate the brain have been conducted by the research group of Prof. Sakhrat Khizroev at Florida International University (FIU).|$|R
40|$|<b>Apolipoprotein</b> (apo) <b>E</b> plays a {{critical}} role in cholesterol transport, through high affinity binding to the low density lipoprotein receptor. This interaction requires apoE to be associated with a lipoprotein particle. To determine the structure of biologically active apoE on a lipoprotein particle, we crystallized dipalmitoylphosphatidylcholine particles containing two apoE molecules and determined the molecular envelope of apoE at 10 angstrom resolution. On the basis of the molecular envelope and supporting biochemical evidence, we propose a model in which each apoE molecule is folded into a helical hairpin with the binding region for the low density lipoprotein receptor at its apex...|$|R
2500|$|Sulfatides {{in brain}} tissue {{has been studied}} by looking at <b>apolipoprotein</b> <b>E</b> (apoE), {{specifically}} the ε4 allele. The ε4 allele of <b>apolipoprotein</b> <b>E</b> is the only known genetic risk factor to significantly indicate late onset Alzheimer's disease.|$|E
2500|$|CR {{cells secrete}} the {{extracellular}} matrix protein reelin, which is critically {{involved in the}} control of radial neuronal migration through a signaling pathway, including the very low density lipoprotein receptor (VLDLR), the <b>apolipoprotein</b> <b>E</b> receptor type 2 (ApoER2), and the cytoplasmic adapter protein disabled 1 (Dab1). In early cortical development in mice, mutations of Dab1, VLDLR, and ApoER2, generate similar abnormal phenotypes, called [...] reeler-like phenotype. It performs several abnormal processes in brain development, such as forming an outside to inside gradient, forming cells in an oblique orientation. Therefore, CR cells control two processes: detachment from radial glia and somal translocation {{in the formation of}} cortical layers. In addition, the reeler type also manifests a poor organization of the Purkinje cell plate(PP) and the inferior olivary complex(IOC).|$|E
5000|$|APOE: <b>Apolipoprotein</b> <b>E,</b> gene {{associated}} with Alzheimer's disease. Gene map locus 19q13.2 ...|$|E
40|$|To {{determine}} if <b>apolipoprotein</b> (apo) <b>E</b> polymorphism influences postprandial lipemia and hence can {{help explain the}} wide range of lipemic responses to a standardized fat meal observed previously, blood samples were collected from 25 healthy men whose postprandial responses to a standardized fat meal had been measured. Venous blood samples had been obtained before the fat meal (0. 73 g fat/kg containing vitamin A) and hourly thereafter for 8 hours, plasma and chylomicron triacylglyceride (TAG) concentrations had been determined, and retinyl esters (REs) in the chylomicron and nonchylomicron fractions had been measured. The original results wer...|$|R
40|$|Low density lipoproteins (LDL) {{and high}} density lipoproteins (HDL) from serum stimulate signal-transduction {{pathways}} and exocytosis in rat alveolar type II cells. Both LDL and HDL stimulated primary cultures of type II cells to secrete phosphatidylcholine (PtdCho), the major phospholipid component of pulmonary surfactant. The effects on secretion were preceded temporally by stimulation of inositol phospholipid catabolism, calcium mobilization, and translocation of protein kinase C from cytosolic to membrane compartments. Heparin, which blocks the binding of ligands to the LDL receptor, completely inhibited {{the effects of}} LDL on signal transduction and PtdCho secretion but did not inhibit the effects of HDL. Unilamellar PtdCho liposomes the size of native LDL {{had no effect on}} type II cells; however, PtdCho complexes containing either <b>apolipoproteins</b> <b>E</b> or A-I stimulated both signal transduction and PtdCho secretion. LDL receptors were present in type II cell membranes by immunoblotting. In contrast to findings with hepatic membranes, type II cells exhibited two major bands of 130 kDa and 120 kDa and a minor band at 230 kDa that also was present under reducing conditions. These results are consistent with our hypothesis that the LDL-receptor pathway functions in vivo to deliver cholesterol to type II cells and that this process is coupled to surfactant assembly and secretion via signal-transduction pathway(s). HDL elicits similar responses independent of the LDL receptor, suggesting that type II cells may use the selective uptake pathway to obtain cholesterol or that HDL triggers signal transduction by mechanisms unrelated to lipid delivery...|$|R
40|$|Familial {{hypercholesterolemia}} (FH) is a codominant disorder due to {{a variety}} of mutations of the low-density lipoprotein (LDL) receptor gene that result in an elevation of plasma LDL-cholesterol (LDL-C). Plasma levels of LDL-C show large interindividual variation even in subjects carrying the same mutation of the LDL receptor gene. This variability may be due to genetic factors (modifier genes). Several surveys indicate that the overall contribution of common polymorphisms of modifier genes (such as the genes encoding <b>apolipoproteins</b> <b>E</b> and B) to this variability is less than 10 %. In contrast, beta-thalassemia has a profound LDL-lowering effect. This was documented in FH patients identified on the island of Sardinia, in Italy, where 12 % of the inhabitants are carriers of beta-thalassemia {{due to a}} single mutation (Q 39 X) of the beta-globin gene that abolishes the synthesis of beta-globin chain of hemoglobin (beta(o) -thalassemia). Plasma LDL-C in FH heterozygotes carrying the beta(o) -thalassemia trait is 25 % lower than in noncarriers, regardless of the LDL receptor gene mutation. It is likely that this effect is due to two main mechanisms: (1) increased uptake of LDL by the bone marrow to provide cholesterol for the increased proliferation of erythroid progenitor cells and (2) increased production of inflammatory cytokines that reduce the hepatic secretion and increase the catabolism of LDL. In view of its LDL-C-lowering effect, beta-thalassemia trait may protect FH heterozygotes against premature coronary atherosclerosis...|$|R
